Search

everythinglearnresearchcommunity

for

Search:↓

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Finasteride reduces prostate size and PSA levels in young patients.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Early hair loss may indicate prostate issues.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Urinary PSA could be an early marker for enlarged prostate.

Red clover extract-based scalp treatments significantly improved hair volume and reduced hair loss and damage.

DEEPLY ROOTED® supplement seems to effectively improve hair growth and quality in women with no side effects.

PRP therapy significantly improved hair growth in a girl with chronic alopecia areata.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Calcitriol and metformin together are more effective for treating PCOS and lowering MCP-1 than metformin alone.

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

The LustrivaTM BH-002 supplement and hair serum improved women's hair, skin, and nail health and appearance.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

The Hair Diameter Index (HDI) was created to help plan hair restoration surgery after finding that visual hair density is linked to hair count and thickness, not volume.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Certain polymers can stick to hair and increase volume, working best at a pH of 7 to 9.

High BMI worsens hair growth in women with PCOS.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

There is no link between hair loss and prostate enlargement.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Finasteride may cause male infertility, stopping it can help.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.